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Abstract

Root resorption is a frequent unwanted occurrence during orthodontic treatment. Biological
factors include the quantity of specific inflammatory mediators, growth factors, and hormones as
well as an individual’s specific alleles for the genes encoding these mediators. Studies have
shown an association between external apical root resorption (EARR) and the single nucleotide
polymorphism (SNP) at +3954 of the IL-1β gene. Studies have also shown associations between
chronic periodontitis and IL-1β gene polymorphisms in the region of +3954, -511 and -31. All
previous studies to date, have evaluated genetic factors and root resorption in orthodontic
patients in-treatment or post-orthodontic treatment. This study is novel in utilizing genomic
DNA samples from buccal swabs of pre-treatment orthodontic patients to evaluate
polymorphisms in the IL-1β gene at +3954, -511 and -31. Pre-treatment records were used
specifically to determine if short roots (Short Root Anomaly) and selected IL-1β gene
polymorphisms could be used to accurately assess a patient’s risk of root resorption prior to
orthodontic treatment. Subjects were categorized as exhibiting normal root length or with short
roots based upon the root morphology evident on 3D CBCT pre-treatment scans. The sample
size consisted of 52 subjects; 26 subjects exhibiting short root anomaly and 26 subjects
exhibiting root length within normal limits. Samples for DNA analysis were collected by
scraping the inside of the cheek with 10 strokes of a sterile nylon bristle brush. Genomic DNA
was obtained from these samples using the Puregene method (Gentra Systems, Minneapolis,
Minn). PCR amplification of regions encompassing the +3954, -31 and -511 sites was followed
by restriction endonuclease digestion using enzymes recognizing the polymorphic sites.
Agarose gel electrophoresis was used to separate and identify bands specific to each allele and
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determine patient homozygosity and heterozygostiy for each polymorphic site. In our study,
Hispanic and female patients showed a higher prevalence of SRA. There was no association
identified between the IL-1β polymorphisms at -511 or -31 with SRA or normal roots. All of the
patients in the SRA group exhibited the CC genotype for the IL-1β polymorphism at +3954. The
presence of the CC genotype was statistically significant in the patients of Hispanic origin. There
was no statistically significant difference between the presence of any specific genotype among
Caucasian patients. The IL-1β +3954 CC genotype has been reported to increase the risk of root
resorption by decreasing the IL-1β expression and consequently, decreasing alveolar bone
resorption. In contrast, the CT genotype has been reported to increase IL-1β expression, possibly
leading to decreased risk of root resorption by increasing bone remodeling. These findings from
this study suggest that that there may be a genetic basis for Hispanic patients to be at a higher
risk of root resorption compared to Caucasian patients. This study supports the idea that root
resorption is multifactorial and multiple diagnostic measures (CBCT, DNA analysis) should be
incorporated in the orthodontic records process to evaluate risk factors prior to starting any
orthodontic treatment. Further studies can be designed to identify the patients who exhibit the IL1β +3954 CC genotype and follow these patients with regular radiographs and CBCT scans to
evaluate root resorption during the course of orthodontic treatment.
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Chapter 1, Introduction
Root resorption is a frequent undesired side effect during orthodontic treatment. Root
resorption is characterized by a partial loss of root cementum and dentin, leading to shortening of
the roots. The reduction in root length leads to an increased risk of mobility and may result in
loss of the affected tooth. Mechanical or orthodontic treatment-related factors contributing to
root resorption may include excessive tooth movement, excessive root torque, intrusive forces,
excessive force magnitude, and extended treatment duration (Abuabara, 2007). Biological factors
are far less characterized. Biological factors include the quantity of specific inflammatory
mediators, growth factors and hormones, as well as an individual’s specific alleles for the genes
encoding these mediators. It is likely that there is a genetic basis for these individual variations.
External apical root resorption (EARR) may also occur in the absence of orthodontic
treatment. To date, causes of EARR are poorly understood, and it is not possible to predict who
will develop EARR or the extent of involvement (Harris, 1997). A genetic component of EARR
was first hypothesized in 1997 following observations of possible inheritance in patients treated
orthodontically (Harris, 1997). The first description of a potential genetic marker was established
by examining linkage and association between several candidate gene polymorphisms and
EARR in Caucasian American families (R. A. Al-Qawasmi, 2003). The association between
EARR during orthodontic treatment and polymorphisms of the IL-1 (+3954) gene identified by
these authors suggests a role for this cytokine in the pathogenesis of EARR (Bastos Lages,
2009). IL-1 has been frequently correlated with inflammatory events in bones and other
connective tissues. Moreover, IL-1 has been characterized as a potent bone-resorptive cytokine
and several studies have implicated IL-1 as a key component of the complex pathways leading
to root resorption (Bastos Lages, 2009). Since IL-1 is a potent stimulator of bone resorption,
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Al-Qawasmi has proposed that a low expression of this cytokine may result in less resorption of
the cortical bone at the periodontal ligament (PDL) interface. This decrease in bone resorption
would result in prolonged stresses concentrated on the root apices, resulting in hyalinization of
the PDL and root resorption (R. A. Al-Qawasmi, 2003).
Previous studies have relied upon panoramic radiographs and lateral cephalograms to
measure EARR. A more recent study utilized periapical radiographs to improve the accuracy in
measuring and diagnosing EARR (Bastos Lages, 2009). However, the use of periapical
radiographs has also been questioned for EARR measurements (Katona, 2006). It would be
expected that the measurement and characterization of root resorption would be more accurate
with the use of contemporary 3-dimensional imaging, such as Cone Beam Computed
Tomography (CBCT).
All previous studies to date, have evaluated the genetic factors and root resorption in
patients in-treatment or post-orthodontic treatment. These studies do not consider the type of
treatment, the mechanics used, or the duration of treatment. Studies on individual genetic
variation must effectively eliminate the variable aspects of orthodontic treatment if any data is to
be evaluated for a genetic basis of root resorption. This would also suggest that the initial
assessment of root resorption should occur prior to starting treatment. In clinical practice,
orthodontists must make an initial assessment of the probability of root resorption prior to
starting treatment. Pre-treatment radiographic evidence (the presence of short roots) is generally
the only indication of a predisposition to resorption during orthodontic treatment. Volmer Lind in
1972 first identified a condition, which he called “Short Root Anomaly”(LIND, 1972). He
defined SRA as ‘abnormally short, plump roots always affecting the maxillary central incisors
and rarely any other teeth’. There is evidence that this unusual root morphology before
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orthodontic treatment can increase the risk of root resorption during treatment. A recent study
has shown that SRA has a predilection for anterior teeth and occurs more frequently in
individuals of Hispanic origin (Puranik, 2015).
At this time, there is no accurate method to determine a patient’s risk of root resorption
prior to starting orthodontic treatment. Ideally, a simple, non-invasive test could be performed to
screen the genetic pre-disposition of a particular patient. This information at the start of
treatment would allow the clinician to modify or shorten a treatment plan, or even elect not to
treat. Advances in molecular biology, DNA sequencing and large-scale automation have
simplified and reduced the once prohibitive cost of various genetic tests. However, the genetic
basis for any pre-disposition to disease must be completely understood before considering the
application of genetic testing. Unfortunately, current research has not successfully correlated any
gene polymorphisms with a clear predisposition for EARR. One possible reason is the use of
post-treatment records which may tend to over-estimate the number of patients with a genetic
pre-disposition by including those that have root resorption solely due to mechanical, treatment
related factors. The previously reported association between root resorption during orthodontic
treatment and the IL-1 (+3954) polymorphism is a logical site for further study. However,
homozygosity and heterozygosity for each allele at the multiple candidate IL-1 polymorphisms
must be compared with radiographic evidence of pre-treatment short roots in order to describe
any relationship between IL-1 and the presence of short roots (SRA) and the predisposition to
treatment-related root resorption (EARR).
1.1: Purpose of the work
Considering the following well-established observations: 1) short roots predispose an
individual to further resorption, 2) abnormally short roots (SRA) occur more frequently in
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Hispanic populations, 3) alleles of the polymorphic IL-1 gene at +3954 have been associated
with differences in IL-1 expression and 4) alleles of the IL-1 gene at +3954, -511 and -31 have
been associated with chronic periodontitis. At the UNLV SDM Orthodontic clinic, a significant
percentage of the patient population is of Hispanic origin. A frequent observation among these
patients is short incisor and mandibular premolar roots without any previous history of
orthodontic treatment. This unique population is ideal for studying the genetic markers that may
predispose patients with SRA to increased risk of root resorption during orthodontic treatment.

Research Questions and Hypotheses

General Hypothesis
Since IL-1β is a potent stimulator of bone resorption and aids in the recruitment of
osteoclasts during orthodontic tooth movement, low IL-1β expression may result in less
resorption of the bone at the interface with the PDL. This impaired alveolar bone resorption may
result in prolonged stresses on the tooth root and subsequent loss of cementum and dentin. Any
polymorphism that results in decreased IL-1β expression may also result in the appearance of
short roots and EARR.

1. Do patients that exhibit short roots at the start of treatment carry the IL-1β (+3954) C
allele?
Ho – Patients with normal roots carry the IL-1β (+3954) C allele.
HA – Patients that exhibit short roots carry the IL-1β (+3954) C allele.
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2. Do patients that exhibit short roots at the start of treatment carry the IL-1β (-31) T
allele?
Ho – Patients with normal roots carry the IL-1β (-31) T allele.
HA – Patients that exhibit short roots carry the IL-1β (-31) T allele.

3. Do patients that exhibit short roots at the start of treatment carry the IL-1β (-511) C
allele?
Ho – Patients with normal roots carry the IL-1β (-511) C allele.
HA – Patients that exhibit short roots carry the IL-1β (-511) C allele.

5

Chapter 2, Background and Literature Review
Root resorption is a condition that can result in the loss of dentin, cementum and/or bone.
This process can be either physiologic or pathologic and it can be categorized based on: location,
etiology (e.g. infection, trauma), site (e.g. apical, cervical) or a combination of the above.
Common stimulants that can lead to root resorption include bleaching agents (internal
bleaching), pulpal necrosis due to trauma or infection and orthodontic treatment. These
stimulants can initiate root resorption by either acting alone or simultaneously (Bellamy &
Malkhassain).
Root resorption can be classified as cervical root resorption, replacement resorption,
internal resorption and external root resorption. Cervical root resorption is a type of external
resorption affecting the cervical third of the root. Replacement resorption is a pathologic
condition in which cementum, dentin and the periodontal ligament are replaced by bone. This
condition can lead to ankylosis resulting from fusion of tooth and bone. Internal resorption is an
inflammatory condition that can result in loss of dentin, and in severe cases can also affect
cementum of the root. Internal resorption affects the internal aspect of the root following
necrosis of pulp as a result of bacterial infection and /or chronic inflammation and is commonly
found in the cervical region of the tooth. External root resorption involves the outer surface of
the roots, and the most common type of external root resorption is external inflammatory root
resorption. This may be caused by trauma, orthodontic tooth movement and pulpal or periodontal
infections. (American Association of Endodontics, “Glossary of endodontic terms,” 2014; Kuo
T-C, Cheng Y-A, 2005).
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2.1 : Orthodontically Induced Inflammatory Root Resorption (OIIRR)/ External Apical

Root Resorption (EARR)
Orthodontically Induced Inflammatory Root Resorption (OIIRR) is often an unavoidable
consequence of orthodontic tooth movement. Orthodontic tooth movement occurs by resorption
of bone on the pressure side and deposition on the tension side. The response of the tooth under
orthodontic force is related to the magnitude of the force applied. When light forces are applied
to the tooth, remodeling of the bony socket occurs by a relatively painless process called “frontal
resorption.” Application of heavy forces leads to rapidly developing pain, occlusion of the blood
supply to the periodontal ligament and ligament hyalinization. Undermining resorption is the
type of bone resorption occurring as a result of this sterile necrosis of the periodontal ligament on
the pressure side. During orthodontic treatment, the objective is to produce tooth movement by
frontal resorption recognizing that some areas of PDL hyalinization and undermining resorption
will probably occur despite efforts to prevent this (Proffit, 2013).
There are three degrees of severity of OIIRR – cemental resorption with repair, dentinal
resorption with repair and circumferential apical root resorption. Cemental or surface resorption
with remodeling is a process in which the outer cemental layer is resorbed and later it is fully
regenerated or remodeled. Dentinal resorption with repair is a process in which both cementum
and the outer layers of dentin are resorbed and usually repaired with cementum alone. The final
shape of the root after repair may not be identical to the original root form. In circumferential
apical root resorption, shortening of the root occurs by full resorption of the cementum and
dentin of the root apex. Regeneration is impaired due to the loss of apical material beneath the
cementum (Brezniak & Wasserstein, 2009).
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During tooth movement, osteoclasts attack cementum and bone, creating defects in the
root surface. The defects are filled back in with cementum during the repair phase. Shortening of
the root occurs when resorptive cavities fuse at the apex, so that peninsulas of root structure are
cut off as islands. These islands resorb, and although the repair process places new cementum
over the residual root surface, a net loss of root length occurs. This is why, although both the
sides and the apex of the root experience resorption, roots become shorter but not thinner as a
result of orthodontic tooth movement (Proffit, 2013).
OIRR can be further classified as moderate generalized resorption, severe generalized
resorption and severe localized root resorption.
Moderate Generalized Resorption
Despite the potential for repair, root resorption is an unavoidable consequence of
orthodontic treatment especially in patients with longer duration of treatment time. Compared to
other teeth, maxillary incisors show somewhat greater shortening of root length. But all teeth
included in the fixed orthodontic appliance therapy show slight average shortening (Proffit,
2013).
Severe Generalized Resorption
Severe generalized root resorption, fortunately, is rare. Severe generalized root resorption
has been noticed in many individuals without any history of orthodontic treatment. The presence
of severe generalized resorption before orthodontic treatment puts the patient at considerable risk
of further resorption during orthodontic treatment, much more so than a patient with no
pretreatment resorption. Although hormonal imbalances and other metabolic derangements have
been suspected in these susceptible patients, little evidence supports these theories. It was
reported in the 1940s that a deficiency of thyroid hormone could lead to generalized root
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resorption. The etiology of severe generalized resorption is still considered entirely unknown.
Various reports have suggested that the teeth exhibiting thin roots with pointed apices, distorted
root form (dilaceration), or a history of trauma may present with above average root resorption
during the orthodontic treatment. However, these characteristics can be considered as indicators
for moderate resorption than as risk factors for severe root resorption (Proffit, 2013).
Severe Localized Resorption
In some instances, orthodontic treatment may be the cause of severe localized root
resorption. Use of heavy forces for a prolonged duration of time increases the amount of root
resorption. It is increasingly apparent that some individuals are more susceptible to root
resorption. It seems reasonable to presume that the large individual differences relate to genetic
factors. There have been few studies linking genetic factors such as IL-1β gene polymorphisms to
root resorption. Until now, the best way to identify the patients who are likely to experience large
amounts of resorption is to take a panoramic radiograph every 6 to 9 months and evaluate the
amount of resorption (Proffit, 2013). There is no diagnostic method using genetic testing to
evaluate resorption risk prior to the orthodontic treatment.

2.2 Root resorption and Immune system disorders

Activated leukocytes in the peripheral blood, indicative of pathology, suggest a possible
association between pathological conditions affecting the immune system and orthodontic root
resorption (Nishioka, 2006). Excessive OIRR has been noticed in patients who showed signs of
psychological stress and incidence of asthma and allergies when compared to patients not
suffering from any of these conditions.(Davidovitch Z, 2000). Similarly, McNab et al have
reported increased incidence of EARR in an asthma study group. (McNab, 1999).
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A retrospective study evaluated records of 60 orthodontic patients and 60 pair-matched
controls in a Japanese population. Elevated levels of pro-inflammatory cytokines were reported
in the serum of patients with active periodontal disease. However, no association was found
between gingival inflammation and root resorption. The lack of association was most likely due
to the use of intraoral photographs to detect the status of periodontal health. In addition, no
significant association was found between root resorption and the extraction of permanent teeth.
This study further supports the hypothesis that it is abnormal root morphology and possibly
asthma and allergy that may be the most significant factors for excessive root resorption during
the course of orthodontic treatment (Nishioka, 2006).

2.3 Short Root Anomaly

Short-root anomaly (SRA) was first identified in a Swedish population by Volmer Lind
in 1972. SRA can be defined as ‘abnormally short, plump roots mostly affecting both central
incisors almost symmetrically (LIND, 1972). SRA is a rare condition, with a prevalence
estimated at 1.3%. It is more common in female patients and principally affects the premolars
and the maxillary incisors, the apexes of which are rounded rather than the usual pointed shape
(Apajalahti, 2002; Apajalahti, 2003; Pazzini, 2010). Frequency of SRA is fairly low among the
Caucasian population. SRA is fairly common among Japanese and Mongolian populations. Short
rooted central incisors are also common among American-Indians (LIND, 1972). Lind suggested
that SRA is an anomaly of genetic origin as he found that the maxillary central incisors are
typically affected simultaneously and symmetrically, whereas mandibular central incisors are
rarely involved. It has been reported that SRA is 3 times as common in girls as in it is in boys.
The prevalence of the condition varies with race and possesses a familial pattern of inheritance
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(LIND, 1972). An autosomal dominant inheritance pattern was documented in several
individuals with SRA from eight families (Apajalahti, 1999).
A study by C. P. Puranik et al showed a predominantly autosomal dominant inheritance
pattern in Hispanic individuals. They concluded that SRA has a predilection towards anterior
teeth and in individuals of Hispanic descent. Due to the autosomal dominant inheritance pattern,
they proposed the term ‘hereditary idiopathic root malformation’ or HIRM, as a more accurate
name for the anomaly (Puranik, 2015).
Dental anomalies such as hypodontia, supernumerary teeth, invaginated teeth,
microdontia, taurodontia, pulp stones and type I dentin dysplasia have been associated with SRA.
It has also been associated with syndromes, such as Steven-Johnson syndrome and Down
syndrome. SRA has also been associated with exogenous factors, including radiation of the head
and neck or chemotherapy in children with malignant tumors during dental development
(Pazzini, 2010).
The risk of root resorption increases when orthodontic forces are applied to teeth with
short roots, possibly due to the lower root/crown ratio (Kjaer, 1995). Unusual root morphology
present before orthodontic treatment has been associated with increased risk of root
resorption(Weltman B, 2010). During the course of orthodontic treatment significant root
shortening has been reported in patients who present with short roots without any prior history of
orthodontic treatment. (Thongudomporn U, 1998). Root resorption and periodontal disease
leading to the loss of alveolar bone can further compromise the prognosis in a patient who
exhibits SRA.
SRA is not well documented, likely because it is poorly understood and the etiology still
remains unknown. Care should be taken not to misdiagnose SRA as root resorption. Oyama et al
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demonstrated that in a short root model, significant stress was concentrated at the apex of the
roots, enough for the development of root resorption. Thus, orthodontic forces should be applied
with considerable caution in patients exhibiting SRA (Oyama K, 2007). In extreme cases of
SRA, orthodontic movement of teeth is contraindicated (Neto, 2013).

2.4 IL-1β:

IL-1β is an important mediator of the inflammatory response and belongs to the
interleukin-1 family of cytokines. This cytokine is primarily produced by macrophages as a
proprotein, which is subsequently proteolytically cleaved into its final, active form by caspase 1
(CASP1/ICE). The IL-1β gene together with eight genes from the interleukin family form a
cytokine gene cluster on chromosome 2. IL-1β is involved in a variety of cellular activities
including cell proliferation, differentiation, apoptosis and most notably, inflammation. As a
mediator of inflammation, IL-1β has been shown to induce cyclooxygenase-2 in the central
nervous system (CNS), contributing to inflammatory pain hypersensitivity (“IL1B interleukin 1
beta [ Homo sapiens (human) ],” 2017).
It also plays a key role in both acute and chronic inflammation as well as autoimmune
disorders (Ke Rena, 2011). IL-1β also contributes to homeostatic functions of the body including
regulation of sleep, feeding and body temperature (Braddock M, 2004; Dinarello CA, 1996).
However, an imbalance in IL-1β expression has been shown to elicit pathophysiological changes
including rheumatoid arthritis, inflammatory bowel disease, neuropathic pain, osteoarthritis,
multiple sclerosis, vascular disease and Alzheimer’s disease (Braddock M, 2004; CA, 2004;
Dinarello CA, 1996). Numerous studies have reported that multiple auto-inflammatory diseases
may, in fact, result from mutations within genes, resulting in an over production of IL-1β and
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consequent disease states (Church LD, 2008; Ke Rena, 2011; Stojanov S, 2005). Not all
inflammation is detrimental however as IL-1β has been shown to be beneficial in cases of sterile
inflammation such as orthodontic tooth movement (OTM) and apoptosis.
The IL-1β gene is highly polymorphic and many studies have confirmed C and T base
substitutions at the following positions: –511 (C-T), –31 (T-C) and +3954 (C-T). The -511 (C-T)
and -31 (T-C) substitutions occur in the promoter region and demonstrate high linkage
disequilibrium, which suggests that these mutations typically occur in unison (El-Omar EM,
2000; Machado JC, 2001; Xu, 2013). The -31 (T-C) substitution causes a disruption in the TATA
box motif, which has been shown to affect the binding affinity of various transcription factors to
the promoter, resulting in a change in IL-1β transcription (Chen H, 2006; El-Omar EM, 2000;
Lind H, 2007). In contrast, the +3954 (C-T) substitution occurs within the IL-1β gene at exon 5
as a synonymous single nucleotide polymorphism (SNP). Within the literature, both the -511T
and +3954T alleles have been shown to increase IL-1β secretion from lipopolysaccharideinduced protein secretions (Hall SK, 2004; Hernandez-Guerrero C, 2003; Pociot F, 1992; Xu,
2013). In children between the ages of 6-18 years old, increased allergic asthma risk has been
associated with the +3954 polymorphisms. Serum levels of IL-1β was also increased in
asthmatic children as compared to the healthy control (Sobkowiak, 2017).

2.5 IL-1β polymorphism +3954, -31, -511 and Periodontitis

Periodontal disease is usually a chronic inflammation triggered by pathogens such as
Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Expression of
proinflammatory cytokines such as IL-1β are triggered by the presence of periodontal pathogens.
Due to its bone resorptive and proinflammatory properties, IL-1β has been associated with
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increased tissue destruction. The severity of periodontal disease has been correlated with
increased levels of IL-1β in the gingival crevicular fluid (Ferreira, 2008).
IL-1α and IL-1β polymorphisms have been associated with increased periodontal disease
and tooth loss as well as with type II diabetes and coronary heart disease (CHD). Compared to
the wild-type IL-1β, diabetics with the IL-1β genotype CT or TT exhibited a more severe
periodontal disease, which suggests that these genotypes may increase the inflammatory
response. Another study reported a decrease in mean alveolar bone level in patients with CHD
associated with these same genotypes, which further suggests the involvement of these
polymorphisms in inflammation (Dinarello, 2011).
IL-1β is a key regulator of the host response and is a potent bone resorbing factor. It has
been reported that single nucleotide polymorphisms (SNPs) in the IL-1β gene are associated with
increased susceptibility to chronic periodontitis (Arora, 2017; Loos BG, 2015). Various ethnic
populations are known to have varying susceptibility to chronic periodontitis owing to SNPs in
the IL-1β gene (Wu X, 2015). It is estimated that approximately 30% of the Caucasian
population has the IL-1β genotype polymorphism that is associated with increased susceptibility
to chronic periodontitis (Arora, Shelly; 2017; Wu X, 2015).
Several studies have shown that an individual with allele C at IL-1β +3954 is associated
with a high risk of developing aggressive periodontitis(Abhijeet Rajendra Shete, 2010; Diehl SR,
1999). The promoter sequence is a potential source for polymorphisms, which would result in
altered gene expression. Several SNPs within the regulatory region of cytokine genes are
associated with altered gene expression. The haplotype consisting of the C allele at -31 and the T
allele at -511 has been associated with a 2 to 3-fold increase in lipopolysaccharide-induced IL-1β
protein secretion. Thus, a haplotype study for the IL-1β gene is crucial as the -511 and -31
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polymorphisms may influence the susceptibility and prognosis of disease through the IL-1β
mediated inflammatory response (Abhijeet Rajendra Shete, 2010; Hall SK, 2004). A more recent
study identified a strong association between the CT genotype at IL-1β +3954 and the TT
genotype at IL-1β -511 with chronic periodontitis. However, no significant association with the
disease was noted at the -31 polymorphism (Amirisetty, 2015).

2.6 IL-1β polymorphism +3954 and root resorption

Several studies have reported an increased level of IL-1β in both the gingival tissue and
the gingival crevicular fluid of patients undergoing orthodontic treatment. This cytokine has also
been associated with bone resorption accompanying orthodontic tooth movement. (R. A. AlQawasmi, 2003; Alhashimi N, 2001; Grieve WG, 1994; Lehky L, 1988; Lynch PR, 1988; Sharp
LB, 1991). Patients undergoing orthodontic treatment exhibited variations in the level of IL-1β
and these variations were correlated with individual differences in the amount of tooth
movement (Iwasaki LR, 2001; Rossi M, Whitcomb S, 1996). This may contribute to EARR
susceptibility depending on the level of IL-1β expression (Davidovitch Z, 1991). These
differences in expression may be attributed, in part, to the alleles at IL-1β gene polymorphisms.
For example, the T allele at +3954 has been associated with a 4-fold increase in IL-1β production
(Al-Qawasmi, 2003; Pociot F, 1992).
The first study to describe the association between IL-1β gene polymorphisms and EARR
during orthodontic treatment was carried out by Al-Qawasmi et al. (2003). Among all teeth
studied, maxillary central incisors exhibited the highest heritability for EARR. Consequently,
these teeth are usually the most severely affected by root resorption during orthodontic treatment
(R. A. Al-Qawasmi, 2003; Harris, 1997). The transmission of haplotypes, including the C allele
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at +3954, was also demonstrated to increase the risk of EARR. On the contrary, transmission of
haplotypes which included the T allele at +3954 decreased susceptibility to EARR, which further
emphasizes the role of genetic susceptibility to EARR (R. A. Al-Qawasmi, 2003). From AlQawasmi’s study (2003), it can be noted that there is a correlation between in vitro IL-1β
expression and the IL-1β polymorphisms associated with EARR in orthodontic patients.
Specifically, allele C of the IL-1β polymorphism at +3954 is associated with a relatively low
expression of IL-1 β (Endres S,1989; Pociot F, 1992). A 4-fold increase in IL-1β expression has
been noted in cell from patients who are homozygous for the IL-1β +3954 T allele.
Heterozygous CT cells produce 2-fold more IL-1β as compared to the cells from those
homozygous for allele T (di Giovine FS, 1995; Pociot F, 1992).
Since IL-1 β is a potent stimulator of bone resorption and aids in the recruitment of
osteoclasts during orthodontic tooth movement, low IL-1 β expression in the case of the C allele
at +3954 may result in less resorption of the bone at the cortical bone interface with the PDL (R.
A. Al-Qawasmi, 2003; Alhashimi N, 2001; Sharp LB, 1991). Al-Qawasmi et al (2003)
suggested that excessive root resorption associated with the C allele of IL-1β at +3954 may be
due to impaired alveolar bone resorption resulting in prolonged stresses on the adjacent tooth
root and subsequent loss of cementum and dentin (R. A. Al-Qawasmi, 2003; WE, 2000).
Research conducted with IL-1β knockout mice showed that root resorption associated with
orthodontic tooth movement may, in fact, be mediated through a decreased rate of alveolar bone
resorption, adding further evidence to support the hypothesis that a sufficient level of IL-1β
expression is required to support bone resorption while maintaining root cementum (R. A. AlQawasmi, 2003; R. a Al-Qawasmi, 2004). These findings contradict the original hypothesis that
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increased severity of EARR after orthodontic treatment may be related to an increased
expression of IL-1 β leading to increased resorption of alveolar bone (Engstrom C, 1988).
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Chapter 3, Materials and Methods:
3.1 Study Design
This case control study was conducted from March of 2016 to November of 2017 and
sampled patients of record from the UNLV Orthodontic Clinic. The study was carried out with
written informed consent from the subjects and their parents. The protocol was approved by the
Biomedical Sciences IRB at the University of Nevada Las Vegas Office of Research Integrity
(protocol number – 944227). A total of 52 patients were included in the study. Twenty-six
patients were included in the SRA group with 2 or more teeth exhibiting short roots. The mean
age in the short root group was 16.7 years (age range 12 – 37 years) with 15 female patients and
11 male patients. The control group included 26 subjects exhibiting normal root length. The
mean age in the control group was 16.8 years (age range 13-30 years) with 9 female patients and
17 male patients. In the SRA group, 23 patients were Hispanic, 1 was Asian and 2 were
Caucasian. The Control group consisted of 9 Hispanic, 3 Asian, 3 African American and 11
Caucasian patients.
3.2 Selection of Study Subjects
Patients were selected for the study using the following criteria:
1) No previous history of orthodontic treatment
2) All or most of the permanent teeth erupted and root formation completed except for 2nd
and 3rd molars
3) SRA group – Patients exhibited 2 or more teeth with short roots
4) Control group – All teeth exhibited normal root length
5) No history of trauma to the teeth exhibiting short roots
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Panoramic radiographs and CBCT scans are obtained as a standard procedure for
orthodontic diagnostic records at the UNLV SDM orthodontic clinic. Panoramic radiographs
were used as an initial screening tool to identify patients with short roots. The presence of short
roots was confirmed using volumetric analysis from the Cone Beam Computed Tomography
(CBCT) (Fig.1). Roots were considered short if they were visually short and plump (LIND,
1972). All patients were randomly selected for the control group with no bias for age, sex or
ethnicity. Once root morphology was confirmed, all patients and their x-rays were de-identified
and assigned a random number using a random number generator application (Pretty Random for
Apple iPhone).

Figure 1. 3D Volumetric analysis of patient #398 exhibiting short roots on central incisors and
bicuspids.

3.3 Clinical Procedures
The subjects providing the sample had not consumed any food or drink in the 60 min
prior to sample collection. To collect the buccal cells, the buccal mucosa was scraped 10 times
on both sides of the cheek in a rolling motion using a buccal collection brush (Gentra Puregene
Buccal Cell Kit, #158845). Cell lysis solution (300 μl) was dispensed into a 1.5 ml
microcentrifuge tube to begin lysis. The collection brush was removed from its handle using
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sterile scissors, and the detached head was placed in the tube. All of the samples were processed
within 48 hours after collection.
3.4 DNA Purification
The Gentra Puregene Buccal Cell Kit (#158845) was used to isolate genomic DNA from
all buccal cell samples. All steps followed the manufacturer’s instructions and are described in
detail below.

1) To achieve maximum yield, 1.5 µl of Puregene Proteinase K was added to the 1.5 ml
microcentrifuge tube containing the collection brush, mixed by inverting 25 times, and
then incubated at 55°C overnight.
2) The collection brush head was removed from the Cell Lysis Solution, scraping it on the
sides of the tube to recover as much liquid as possible.
3) As RNA-free DNA was required, 1.5 µl of RNase A Solution was added and vortexed.
Samples were incubated for 45 min at 37°C.
4) Samples were then incubated for 1 min on ice to quickly cool the samples.
5) 100 µl of Protein Precipitation Solution was added and vortexed vigorously for 30 s at
high speed.
6) Samples were incubated for 10 min on ice.
7) Samples were centrifuged for 5 min at 16,000 x g. The precipitated proteins formed a
tight pellet. If the protein pellet was not tight, samples were incubated on ice for an
additional 5 min and centrifugation repeated.
8) 300 µl isopropanol and 0.5 µl Glycogen solution were pipetted into a clean 1.5 ml
centrifuge tube, and the supernatant was added from the previous step.
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9) Samples were mixed by inverting gently 50 times.
10) Samples were centrifuged for 5 min at 16,000 x g.
11) The supernatant was carefully discarded, and the tube was drained by inverting on a clean
piece of absorbent paper, taking care that the pellet remained in the tube.
12) 70% (300 µl) ethanol was added to each tube and inverted several times to wash the DNA
pellet.
13) The samples were centrifuged for 5 min at 16,000 x g.
14) The supernatant was carefully discarded. The tube was drained on a clean piece of
absorbent paper, taking care that the pellet remained in the tube. Samples were allowed to
air dry for 5 min.
15) DNA Hydration Solution (100 µl) was added to each tube and vortexed for 5 s at medium
speed to mix.
16) Samples were incubated at 65°C for 1 h to dissolve the DNA.
17) Samples were then centrifuged briefly and stored in the freezer at -20°C.
18) DNA yield was determining using a spectrophotometer. Dilution of 1:80 was used for the
determination. 790 µl of Deionized Ultra-Filtered Water (D.I.U.F) was mixed with 10 µl
of purified genomic patient DNA. Optical density (O.D) at 260 nm and 280 nm was
recorded for all of the samples. The ratio of the absorbance maximum at 260 nm to the
absorbance at 280 nm was used to calculate concentration and purity.
3.5 PCR amplification and Digest
Each patient’s genomic DNA sample was diluted to the concentration of 50 g/l. A
separate PCR reaction for amplification of a region encompassing each site (IL-1 +3954, -31, 511) was prepared by adding 4 l patient DNA (50 g/l), 25 l of Promega GoTaQ master
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mix (M7132), 2.5 l of forward primer (10 M) and 2.5 l of reverse primer (10M) for IL-1


+3954, -31, and - 511 (Table 1) with nuclease free H2O (16 l) to a total volume of 50 l.
PCR thermocycling conditions for the +3954 and -511 amplifications consisted of the
following steps: Initial denaturation at 95°C for 3 minutes followed by 39 cycles of 95°C for 1
minute, 57°C for 1 minute, and 72°C at 1 minute. A final extension was performed at 72°C for 8
minutes. Reactions were held at 4°C until freezing at -20°C.
PCR thermocycling conditions for the -31 amplifications consisted of the following steps:
Initial denaturation at 95°C for 3 minutes followed by 39 cycles of 95°C for 1 minute, 51°C for 1
minute, and 72°C at 1 minute. A final extension was performed at 72°C for 8 minutes. Reactions
were held at 4°C until freezing at -20°C.
The amplified products were 194 bp for the region encompassing the +3954 site, 155 bp
for the -511 site and 239 bp for the -31 site. The +3954 amplified products were digested
overnight with TaqI at 37°C. The -511 product was digested overnight with AvaI at 37°C. The 31 products were digested overnight with AluI at 37°C. Following the overnight digest, products
were stored at -20°C.
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Table 1. Primer Sequence
Forward primer: 5’-CTCAGGTGTCCTCGAAGAAATCAA-3’
IL-1β +3954
Reverse primer: 5’- GCTTTTTTGCTGTGAGTCCCG-3’
Forward primer: 5’-GCCTGAACCCTGCATACCGT-3’
IL-1β -511
Reverse primer: 5’-GCCAATAGCCCTCCCTGTCT-3’
Forward primer: 5’-AGAAGCTTCCACCAATACTC-3’
IL-1β -31
Reverse primer: 5’-AGCACCTAGTTGTAAGGAAG-3’

Figure 2- IL-1B single nucleotide polymorphisms and restriction endonuclease
recognition sites
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3.6 Agarose gel electrophoresis
Full-length PCR products and digests for each subject were resolved with agarose gel
electrophoresis. All agarose gels were prepared at 2.5% containing ethidium bromide at a
concentration of 500 ng/ml. A 100 bp molecular weight standard was included on all gels.
Visualization of the gels was performed under UV light and images of the gels were captured
using a Kodak Gel Logic 100 Imaging System (Rochester, NY). Bands representative of full
length amplified PCR products and digested fragments were identified and noted based on the
relative size of the bands compared to the 100 bp standard.
The TaqI digest of amplified +3954 site products yielded a 182 bp band when a T allele
was present, since the TaqI site was not present. When a C allele was present at +3954, the
cleavage at the preserved TaqI site resulted in bands of 85bp and 97bp. In both cases, a 12bp
band was produced that was designed in the primers as a control site, although this was rarely
visible on any agarose gel.
The AluI digest of amplified -31 site products yielded a single 239 bp band when a C
allele was present, since the AluI site was not present. When a T allele was present at -31, the
cleavage at the preserved AluI site resulted in a band of 137 bp and 102 bp.
The AvaI digest of amplified -511 site products yielded a single 155 bp band when a T
allele was present, since a suitable AvaI site was not present. When a C allele was present at 511, the cleavage at the AvaI site resulted in bands of 92 bp and 63 bp.
3.7 DNA sequencing
A sample of amplified full length amplified products from patients representing each
genotype for all 3 sites +3954, -31 and -511 were randomly selected for DNA sequencing to
verify the accuracy of sites identified by restriction endonuclease digests. PCR products were
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sequenced by Functional Biosciences, Inc. (Madison, WI). The data files were viewed using
CodonCode Aligner 7.1.2 for Mac OS X. At the time of sequencing, no patients with the TT
genotype at the +3954 site were identified.
3.8 Statistical Analysis:
The Chi-square test was used to investigate the distribution of the genotype and the allelic
frequency in the short root and control groups for each IL-1β gene polymorphism. The Odds
ratio (OR) was used to calculate the risk of patients presenting with SRA with each of the
genotypes. Significance level was set at 5% and all chi-square tests were performed using
Microsoft Excel (version 15.40) and the odds ratio was calculated using a web based calculator
(www.graphpad.com).
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Chapter 4, Results:
A total of 52 patients were evaluated for the IL-1β polymorphism at +3954, -511 and -31.
Twenty-six patients exhibited short roots on two or more teeth and were categorized as SRA. An
additional 26 patients were selected randomly and categorized as control if they exhibited roots
within normal length.
5.1 Ethnic and sexual diversity among SRA and control
Samples were randomly collected from patients at the UNLV Orthodontic Clinic after
confirming the presence of short roots or normal roots with panoramic radiographs and Cone
Beam Computed Tomography (CBCT). The total sample (n=52) included 32 patients of
Hispanic origin (61%), 13 patients of Caucasian origin (25%), 4 patients of Asian origin (8%)
and 3 patients of African-American (6%) origin (Table 2). In the SRA group, 23 patients were
Hispanic (88%), 2 were Caucasian (8%) and 1 was Asian (4%) (n=26) (Fig.3). In the control
group 9 patients were Hispanic (33%), 11 were Caucasian (41%), 3 were Asian (11%) and 3
were African-American (15%) (n=26) (Fig.3).
Table 2. Ethnic Diversity, n = 52
Hispanic
Caucasian

32
13

Asian

4

African-American

3
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Ethnic Diversity, SRA vs Control
30
25
20
15
10
5
0

SRA

Control

African-American

0

3

Asian

1

3

Caucasian

2

11

Hispanic

23

9

Figure. 3 Ethnic Diversity, SRA vs Control

Twenty-eight patients were males (54%) and 24 were females in the total sample (46%)
(n=52) (Table 3). 11 patients were male (42%) and 15 were female (58%) in the SRA group,
while 17 patients were male (65%) and 9 (35%) were female in the control group (Fig. 4).

Table 3. Sexual Diversity, n = 52
Male

28

Female

24

27

Sexual Diversity, SRA vs Control
30
25
20
15
10
5
0

SRA

Control

Female

15

9

Male

11

17

Figure 4. Sexual Diversity, SRA vs Control

5.2 IL-1β +3954 Polymorphism
The results from the DNA sequencing were 100% concordant with our analysis using
restriction digest and agarose gel electrophoresis for the +3954 polymorphism. Representative
patient #237 exhibited the CC genotype and patient #634 exhibited the CT genotype (Fig. 5).
These findings were confirmed with DNA sequencing (Fig 6 & 7).
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Figure 5. Band pattern for +3954, patients #237 and #634

Figure. 6 DNA sequence confirming CC genotype patient #237 (blue peak)

29

Figure. 7 DNA sequence confirming CT genotype patient #634 (blue and red peak)
Following genotype analysis, 79% of the total patients were identified as homozygous
CC, 2% of the patients were homozygous TT and 19% of the patients were heterozygous CT
(n=52) (Table 4). The presence of the CC genotype in +3954 was statistically significant
compared to the presence of the TT genotype and CT genotype (n=52) (p = 0.0009). SRA was
observed in 100% of the patients that exhibited the CC genotype (Fig.8). This difference was
statistically significant (n=26) (p = 0.0001). The presence of the CC genotype was observed in
79% of the patients exhibiting normal roots, while 2% had the TT genotype and 19% had the CT
genotype (Fig.8). This difference was statistically significant (n=26) (p = 0.0003).
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Table 4. IL-1β +3954 Genotype distribution in the total sample, n = 52
CC

41

TT

1

CT

10

+3954 Genotype comparison, SRA vs
Control
30
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SRA

Control

0
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TT

0

1

CC

26

15

Figure 8. +3954 Genotype comparison, SRA vs Control
The CC genotype at +3954 was the most prevalent among all males (82%). All other
males were the CT genotype at +3954 (Table 5). The presence of the CC genotype was
statistically significant when compared to the TT and CT genotype (n=28) (p = 0.013). In the
SRA group, 100% of the male patients exhibited the CC genotype and this difference was
statistically significant (n=11) (p = 0.0001) (Fig. 9). In the control group, 71% of males exhibited
the CC genotype while 29% exhibited the CT genotype (Fig. 9). This difference was statistically
significant (n=17) (p =0.0001).
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Table 5. IL-1β +3954 Genotype distribution in the total male sample, n = 28
CC

23

TT

0

CT

5

+3954 Genotype distribution of all
male patients, SRA vs Control
18
16
14
12
10
8
6
4
2
0
CT

SRA

Control

0

6

TT

0

0

CC

11

11

Figure 9. +3954 Genotype distribution of male patients, SRA vs Control
The CC genotype at +3954 was the most prevalent among all female patients (74%)
while 4% of female patients exhibited the TT genotype and 22% exhibited the CT genotype
(Table 6). The presence of the CC genotype was statistically significant as compared to the TT or
the CT genotype (n=24) (p = 0.003). In the SRA group 100% of females exhibited the CC
genotype (Fig. 10). This difference was statistically significant (n=15) (p = 0.0001). In the
control group, 44% of the females exhibited the CC genotype, 45% exhibited the CT genotype,

32

while 11% exhibited the TT genotype (Fig. 10). This difference was not statistically significant
(n=9) (p = 0.3)
Table 6. IL-1β +3954 Genotype distribution in the total female sample, n = 24
CC

19

TT

1

CT

4

+3954 Genotype distribution of all
female patients, SRA vs Control
16
14
12
10
8
6
4
2
0
CT
TT
CC

SRA
0

Control
4

0

1

15

4

Figure 10. +3954 Genotype distribution of all female patients, SRA vs Control

97% of the patients of all Hispanic origin exhibited a CC genotype at +3954 and 3% of
the Hispanic patients exhibited a CT genotype (Table 7). The presence of the CC genotype was
statistically significant as compared to the other genotypes (n=32) (p = 0.0001). 100% of the
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patients of Hispanic origin in the SRA group exhibited a CC genotype (Fig. 11). This difference
was statistically significant (n=23) (p = 0.0001). 89% of the patients of Hispanic origin in the
control group exhibited the CC genotype while 11% had the TT genotype (Fig. 11). This
difference was statistically significant (n=9) (p = 0.0001).
Table 7. IL-1β +3954 Genotype distribution in the total Hispanic sample, n = 32
CC

31

TT

1

CT

0

+3954 Genotype distribution of all
Hispanic patients, SRA vs Control
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Figure 11. +3954 Genotype distribution of all Hispanic patients, SRA vs Control
38% of the patients of all Caucasian origin exhibited the CC genotype at +3954 and 62%
of the Caucasian patients exhibited the CT genotype (Table 8). The presence of the CC genotype
was not statistically significant when compared to the CT genotype (n=13) (p = 0.4). 100% of
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the patients of Caucasian origin in the SRA group exhibited the CC genotype (Fig. 12). This
difference was statistically significant (n=2) (p = 0.04). 73% of the patients of Caucasian origin
in the control group exhibited the CT genotype and 27% exhibited the CC genotype (Fig. 12).
This difference was not statistically significant (n=11) (p = 0.1).
Table 8. IL-1β +3954 Genotype distribution in the total Caucasian sample, n = 13
CC

5

TT

0

CT

8

+3954 Genotype distribution of all
Caucasian patients, SRA vs Control
12
10
8
6
4
2
0

SRA

Control

CT

0

8

TT

0

0

CC

2

3

Figure 12. +3954 distribution of all Caucasian patients, SRA vs Control
The CC genotype at +3954 was the most prevalent among all of the patients of Asian
(100%) origin, showing a statistically significant difference (n=4) (p =0.0001) (Table 9). 67% of
the patients exhibited the CC genotype and 33% exhibited the CT genotype among patients of
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African-American origin, however this difference was not statistically significant (n=3) (p = 0.2)
(Table 10).
Table 9. IL-1β +3954 Genotype distribution in the total Asian sample, n = 4
CC

4

TT

0

CT

0

Table 10. IL-1β +3954 Genotype distribution in the total African-American sample, n = 3
CC

2

TT

0

CT

1

From the Odds ratio calculation, patients with the CC genotype at +3954 had 12 times
more chance of presenting with SRA as compared to patients with the TT genotype (OR = 12).
5.3 IL-1β -511 Polymorphism
The results from the DNA sequencing were 100% concordant with our analysis using
restriction digest and agarose gel electrophoresis for the -511 site. Representative patient #237
exhibited the TT genotype, patient #634 exhibited the CC genotype and patient #686 exhibited
the CT genotype (Fig. 13). These findings were confirmed with DNA sequencing (Fig. 14, 15
and 16).
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Figure 13. Band pattern for -511, patients #237, 634 and 686

Figure. 14 DNA sequence confirming TT genotype, patient #237 (red peak)
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Figure. 15 DNA sequence confirming CC genotype, patient #634(blue peak)

Figure. 16 DNA sequence confirming CT genotype, patient #686 (red and blue peak)

38

27% of the total patients exhibited the CC genotype at -511, 25% of the patients exhibited
the TT genotype and 48% patients exhibited the CT genotype (Table 11). This difference was not
statistically significant (n = 52) (p = 0.9). In the SRA group, 31% of the patients exhibited the
CC genotype at -511, 31% of the patients exhibited the TT genotype and 38% of the patients
exhibited the CT genotype (Fig. 17). There was no statistical significance between the genotypes
in the SRA group (n=26) (p = 0.5). In the control group 23% of the patients exhibited the CC
genotype, 19% of the patients exhibited the TT genotype and 58% of the patients exhibited the
CT genotype (Fig. 17). This difference was not statistically significant (n=26) (p = 0.7).
Table 11. IL-1β -511 Genotype distribution in the total sample, n = 52
CC

14

TT

13

CT

25

-511 Genotype Comparison, SRA vs
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6

Figure 17. Genotype Comparison, SRA vs Control
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Among all of the male patients in the study, 29% exhibited the CC genotype at -511, 32%
exhibited the TT genotype and 39% exhibited the CT genotype (Table 12). This difference was
not statistically significant (n=28) (p = 0.5). In the SRA group, 37% of males exhibited the CC
genotype at -511, 36% exhibited the TT genotype and 27% exhibited the CT genotype (Fig. 18).
This difference was not statistically significant (n=11) (p = 0.3). In the control group, 24% of the
male patients exhibited the CC genotype at -511, 29% exhibited the TT genotype and 47% of the
patients exhibited the CT genotype (Fig. 18). This difference was not statistically significant
(n=17) (p=0.9).
Table 12. IL-1β -511 Genotype distribution in the total male sample, n = 28
IL-1β -511 Genotype in total male sample, n = 28
CC

8

TT

9

CT

11
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-511 Genotype distribution of all male
patients, SRA vs Control
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Figure 18. -511 Genotype distribution of all male patients, SRA vs Control
Among all of the female patients in the study, 25% exhibited the CC genotype at -511,
17% exhibited the TT genotype and 58% exhibited the CT genotype (Table 13). This difference
was not statistically significant (n=24) (p = 0.6). In the SRA group, 27% of the females exhibited
the CC genotype at -511, 27% exhibited the TT genotype and 46% exhibited the CT genotype
(Fig. 19). There was no statistically significant difference in this group (n=15) (p =0.9). In the
control group, 22% of the female patients exhibited the CC genotype and 78% exhibited the CT
genotype (Fig. 19). This difference was not statistically significant (n=9) (p = 0.1).

Table 13. IL-1β +511 Genotype distribution in the total female sample, n = 24
CC

6

TT

4

CT

14
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-511 Genotype distribution of all
female patients, SRA vs Control
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Figure 19. -511 Genotype distribution of all female patients, SRA vs Control
For the -511 site, there was no statistical difference found among the total patients of
Hispanic origin (p = 0.9). 25% of the patients exhibited the CC genotype, 25% exhibited the TT
genotype and 50% the CT genotype (n=32) (Table 14). 26% of Hispanic patients in the SRA
group exhibited the CC genotype, 30% of the patients exhibited the TT genotype and 44% of
patients exhibited the CT genotype (Fig. 20). This difference was not statistically significant
(n=23) (p=0.7). 11% of the Hispanic patients in the control group exhibited the CC genotype,
22% exhibited the TT genotype and 67% exhibited the CT genotype (Fig. 20). This difference
was not statistically significant (n=9) (p = 0.5)
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Table 14. IL-1β -511 Genotype distribution in the total Hispanic sample, n = 32
CC

8

TT

8

CT

16

-511 Genotype distribution of all
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Figure 20. -511 Genotype distribution of all Hispanic patients, SRA vs Control
Among all of the Caucasian patients, 54% exhibited the CC genotype at the -511 site,
46% exhibited the CT genotype and none showed the presence of the TT genotype (Table 15).
This difference was statistically significant (n=13) (p = 0.02). Within the SRA group, 100% of
the Caucasian patients exhibited the CC genotype (Fig. 21). This difference was statistically
significant (n=2) (p = 0.04). In the control group, 45% of the Caucasian patients exhibited the
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CC genotype and 55% exhibited the CT genotype (Fig. 21). This difference was not statistically
significant (n=13) (p=0.09).
Table 15. IL-1β -511 Genotype distribution in the total Caucasian sample, n = 13
CC

7

TT

0

CT

6
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Figure 21. -511 Genotype distribution of all Caucasian patients, SRA vs Control
75% of all of the Asian patients exhibited the TT genotype at -511, while 25% exhibited
the CT genotype. This difference was not statistically significant (n=4) (p = 0.06) (Table 16).
67% of all the African-American patients exhibited the CT genotype and 33% exhibited the TT
genotype. This difference was not statistically significant (n=3) (p = 0.6) (Table 17).
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Table 16. IL-1β -511 Genotype distribution in the total Asian sample, n = 4
IL-1β -511 Genotype in total Asian sample, n = 4
CC

0

TT

3

CT

1

Table 17. IL-1β -511 Genotype distribution in the total African-American sample, n = 3
IL-1β -511 Genotype in total African-American sample, n = 3
CC

0

TT

1

CT

2

5.4 IL-1β -31 Polymorphism
The results from the DNA sequencing were 100% concordant with our analysis using
restriction digest and agarose gel electrophoresis for the -31 polymorphism. Patient #237
exhibited the CC genotype, patient #634 exhibited TT genotype and patient #686 exhibited CT
genotype (Fig. 22). These findings were confirmed with DNA sequencing (Fig. 23, 24 and 25).
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Figure 22. Band pattern for -31, patient #237, 634 and 686

Figure. 23 DNA sequence confirming CC genotype, patient #237(blue peak)
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Figure. 24 DNA sequence confirming TT genotype, patient # 634(red peak)

Figure. 25 DNA sequence confirming CT genotype, patient #686 (red and blue peak)
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Following analysis of the -31 polymorphism, 31% of the total patients in the study
exhibited the TT genotype, 25% of all patients exhibited the CC genotype and 44% of the total
patients in the study exhibited the CT genotype (Table 18). This difference was not statistically
significant (n=52) (p = 0.5). In the SRA group, 31% of the patients exhibited the TT genotype,
31% exhibited the CC genotype and 38% exhibited the CT genotype at the -31 site (Fig. 26).
There was no statistical significant difference between the genotypes in the SRA group (n=26) (p
= 0.5). In the control group, 31% of the patients exhibited the TT genotype, 19% exhibited the
CC genotype, while 50% of patients exhibited the CT genotype at the -31 site (Fig. 26). This
difference was not statistically significant (n=26) (p = 0.7).
Table 18. IL-1β -31 Genotype distribution in the total sample, n = 52
TT

16

CC

13

CT

23
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Figure 26. -31 Genotype comparison, SRA vs Control

Among all of the male patients in the study, 32% exhibited the TT genotype, 32%
exhibited the CC genotype and 36% of the patients exhibited the CT genotype at the -31 site
(Table. 19). This difference was not statistically significant (n=28) (p = 0.3). In the SRA group,
37% of the males exhibited the TT genotype, 36% exhibited the CC genotype and 27% exhibited
the CT genotype at the -31 site (Fig. 26). This difference was not statistically significant (n=11)
(p = 0.3). In the control group, 30% of males exhibited the TT genotype, 29% exhibited the CC
genotype and 41% exhibited the CT genotype at the -31 site (Fig. 26). This difference was not
statistically significant (n=11) (p = 0.7).
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Table 19. IL-1β -31 Genotype distribution in the total male sample, n = 28
TT

9

CC

9

CT

11
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Figure. 27 -31 Genotype distribution of all male patients, SRA vs Control
Among all of the female patients in the study, 29% exhibited the TT genotype, 17%
exhibited the CC genotype and 54% exhibited the CT genotype (Table. 20). This difference was
not statistically significant (n=24) (p = 0.6). In the SRA group, 27% of females exhibited the TT
genotype, 27% exhibited the CC genotype and 46% exhibited the CT genotype (Fig. 28). There
was no statistically significant difference noted in this group (n=15) (p =0.9). In the control
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group, 33% of females exhibited the TT genotype and 67% exhibited the CT genotype at the -31
site (Fig. 28). This difference was not statistically significant (n=9) (p = 0.2).
Table 20. IL-1β -31 Genotype distribution in the total female sample, n = 24
TT

7

CC

4

CT

13
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Figure 28. -31 Genotype distribution of all female patients, SRA vs Control
Among all of the Hispanic patients, there was no statistical significance (p = 0.6) with
30% of the total Hispanic patients exhibiting the TT genotype, 27% exhibiting the CC genotype
and 43% exhibiting the CT genotype (n=32) (Table 21). In the SRA group, 26% of the Hispanic
patients exhibited the TT genotype, 30% exhibited the CC genotype and 44% of the patients
exhibited the CT genotype at the -31 site (Fig. 29). This difference was not statistically
significant (n=23) (p=0.7). In the control group, 33% of the Hispanic patients exhibited the TT
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genotype, 22% exhibited the CC genotype and 45% exhibited the CT genotype at the -31 site
(Fig. 29). This difference was not statistically significant (n=9) (p = 0.8)
Table 21. IL-1β -31 Genotype distribution in the total Hispanic sample, n = 32
TT

10

CC

8

CT

14
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Figure 29. -31 Genotype distribution of all Hispanic patients, SRA vs Control
Among all Caucasian patients in the study, 54% exhibited the TT genotype and 46%
exhibited the CT genotype at the -31 site (Table 22). This difference was statistically significant
(n=13) (p = 0.02). In the SRA group, 100% of the Caucasian patients exhibited the TT genotype
(Fig. 30). This difference was statistically significant (n=2) (p = 0.04). In the control group, 45%
of the Caucasian patients exhibited the TT genotype and 55% exhibited the CT genotype (Fig.
30). This difference was not statistically significant (n=9) (p=0.09).
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Table 22. IL-1β -31 Genotype distribution in the total Caucasian sample, n = 13
TT

7

CC

0

CT

6
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Figure. 30 -31 Genotype distribution of all Caucasian patients, SRA vs Control
Among all Asian patients in the study, 75% exhibited the CC genotype and 25%
exhibited the CT genotype at the -31 site (Table 23). This difference was not statistically
significant (n=4) (p = 0.06). Among all of the African-American patients, 67% exhibited the CT
genotype and 33% exhibited the TT genotype. This difference was not statistically significant
(n=3) (p = 0.6) (Table 24).
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Table 23. IL-1β -31 Genotype distribution in the total Asian sample, n = 4
IL-1β -31 Genotype in total Asian sample, n = 4
TT

0

CC

3

CT

1

Table 24. IL-1β -31 Genotype distribution in the total African-American sample, n = 3
IL-1β -31 Genotype in total African-American sample, n = 3
CC

0

TT

1

CT

2
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Chapter 5, Discussion:
Root resorption is often an unavoidable consequence of orthodontic treatment. Research
has suggested that heavy forces and prolonged duration of treatment can lead to orthodontically
induced root resorption. Abnormal root morphology can also lead to external root resorption
after orthodontic treatment (Sameshima G T, 2004). Short root anomaly was first described by
Lind in 1972. He described SRA as plump roots that are abnormally short and usually affecting
maxillary central incisors, maxillary premolars and mandibular premolars (LIND, 1972). SRA
can go unidentified because there are no clinical symptoms of this condition and since the
frequency of SRA is low in Caucasian populations, this condition may not be prevalent in
Caucasian dominated regions. Finite element analysis investigating the stress distribution at the
root in different root shapes has shown increased stress loading in short and bent root models
(Oyama K, 2007). From Oyama’s finite element model analysis, it can be concluded that patients
with SRA may be more prone to root resorption during orthodontic treatment as compared to
patients who exhibit normal root length (Oyama K, 2007).
Al-Qawasmi was the first to identify an association between I IL-1β polymorphisms and
root resorption during orthodontic treatment. They specifically described the CC genotype of the
IL-1β polymorphism at +3954 and its association with decreased IL-1β production. They
hypothesized that decreased IL-1β production leads to impaired alveolar bone remodeling
resulting in prolonged stress on the root surface. This in turn leads to increased risk of root
resorption during orthodontic treatment. This theory contradicts other hypotheses that state that
increased root resorption can be associated with increased IL-1β expression, which is also
associated with an increase in alveolar bone remodeling (R. A. Al-Qawasmi, 2003; R. a AlQawasmi, 2004). From the above-mentioned studies, it can be noted that a patient presenting
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with SRA and exhibiting the IL-1β CC genotype at +3954 would be at higher risk for root
resorption during orthodontic treatment (R. A. Al-Qawasmi, 2003; Oyama K, 2007).
IL-1β polymorphisms at -511 and -31 have also been associated with periodontal disease
and several other chronic inflammatory diseases (Amirisetty, 2015). Some studies have reported
an increase in the lipopolysaccharide induced IL-1β expression associated with the IL-1β
polymorphisms at -511 and -31(Hall SK, 2004).
This study was the first of its kind to explore the relationship between SRA and IL-1β
polymorphisms at 3 distinct sites +3954, -511 and -31. Also, this was one of the first studies to
explore the genetic factors that may lead to root resorption during orthodontic treatment among
different ethnicities.
Compared to the previous studies conducted on short root anomaly using peri-apical
radiographs or panoramic radiographs, this study incorporated the use of CBCT. CBCT was
helpful in establishing a more accurate diagnosis of SRA. Proclined incisors can often be
misdiagnosed as having short roots on panoramic radiographs. In our study, during initial patient
selection we noticed that some of the patients who exhibited short roots in panoramic
radiographs presented with no root abnormalities upon CBCT review. Cephalometric analysis
often revealed proclination of these teeth. This indicates that CBCT is an important tool to
accurately diagnose the presence of SRA.
Al-Qawasmi used panoramic radiographs to evaluate root resorption, Lages utilized periapical radiographs in their study (R. A. Al-Qawasmi, 2003; Bastos Lages, 2009). Panoramic
radiographs, lateral cephalometric and peri-apical radiographs provide us with a 2-D image of a
3-D structure. There are limitations with these modalities to accurately diagnose the presence of
short roots. Cephalometric radiographs may not be able to detect the presence of short roots
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accurately due to overlap. In peri-apical radiographs the root length can be elongated or
shortened depending on the angulation of the X-ray and panoramic radiographs may show
distortion depending on where the structure falls in relation to the focal trough. Anterior teeth
can also appear to have short roots in panoramic radiographs depending on their angulation in
the alveolar housing. Our study utilized CBCT to evaluate the presence of short roots, the roots
can be visualized in 3-D and any abnormal root morphology can be visualized accurately.
Lind wrote that the teeth primarily affected by SRA are maxillary incisors, maxillary
premolars and mandibular premolars and rarely other teeth. In our study, we also found that only
maxillary incisors, maxillary premolars and mandibular premolars were affected by SRA. This
finding was similar to the one mentioned in the studies by Lind and Puranik (LIND, 1972;
Puranik, 2015). As described by Puranik, SRA occurs frequently in individuals of Hispanic
origin (Puranik, 2015). In our study 88% of patients in the SRA group were of Hispanic origin
while only 33% of patients in the control group were of Hispanic origin. The frequency of SRA
is generally low in the Caucasian population. Only 8% of patients in the SRA group were of
Caucasian origin and 41% of patients in normal roots were of Caucasian origin. All the patients
in the control group were randomly selected to avoid any ethnic bias. These finding confirms that
SRA is not a common finding in individuals of Caucasian origin but occurs frequently in
Hispanic populations. SRA has been reported to be 3 times more common in females as
compared to males (LIND, 1972). Although the prevalence was not the same as reported by
Lind, 58% of the patients in the SRA group were females as compared to 35% in the control
group. These findings suggest a higher prevalence of SRA in females as compared to males.
No significant differences were seen in the different genotypes at the -511 and -31 sites
between the SRA and control groups. Neither males nor females exhibited any increased
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incidence of any genotype at -511 and -31 sites. No difference was noted among patients of
Hispanic, Asian or African-American origin at both the -511 and -31 sites. No difference was
noted between these ethnicities among SRA and the control group. Caucasian patients showed a
significantly higher TT genotype compared to the CC or CT genotype for IL-1β at -31 and a
higher CC genotype at -511 in the SRA group. In the control group, there was no significant
difference between the genotypes for both the -511 and -31 sites. This data may not be the most
meaningful since the sample size of Caucasian patients in the SRA group was very low (n=2).
No association was seen with the IL-1β -511 and -31 polymorphisms and the presence of
SRA. Both -511 and -31 are located in the promoter region and show high linkage
disequilibrium. In our study we noticed a similar finding, with polymorphisms at -511 and 31almost always exhibiting linkage disequilibrium. The T allele at -511 and the C allele at -31
have been associated with increases in IL-1β production. In our study, we did not find any
significant difference in the presence of different genotypes at the -511 and -31 sites.
In the SRA group, all patients exhibited the CC genotype at +3954. Reports have
suggested that Hispanic patients may be at higher risk for root resorption during orthodontic
treatment (Sameshima GT, 2001). This study found a significant occurrence of the CC genotype
in patients of Hispanic origin. The CC genotype was prevalent in both the SRA and the control
group which may suggest the predisposition of individuals of Hispanic origin towards
orthodontically induced root resorption. It can be concluded from this study that a patient of
Hispanic origin exhibiting SRA and exhibiting the CC genotype (IL-1β +3954 polymorphism)
may present a higher risk of root resorption during orthodontic treatment and care should be
taken during treatment planning.
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100% of the Caucasian patients in the SRA group exhibited the CC genotype (IL-1β
+3954) (n=2). Caucasian patients did not exhibit any significant presence of any genotype,
suggesting that Caucasian patients may be at lower risk to root resorption as compared to
Hispanic patients
All the patients of Asian origin also showed presence of CC genotype though no
significant difference was found in the SRA group. There was no African-American patient in
the SRA group. African-American patients in the control group did not show any significant
difference in the genotype present. The sample size of Asian and African-American patients was
too low to derive any conclusion.
If Hispanic patients do exhibit increased prevalence of the CC genotype at IL-1β +3954,
this might explain the increased presence of the CC genotype in the control group in our study
and the higher number of the CC genotype in the total sample, since 61% of patients were of
Hispanic origin. This study was the first to evaluate the presence of a genetic marker that may be
a risk factor for orthodontically induced root resorption among different ethnicities.
IL-1β (+3954) is located within exon 5 and this exon is in the coding region of the gene.
Although the polymorphism does not result in a missense mutation, it might influence nuclear
RNA stability, mRNA splicing or levels of mRNA expression.
It has been reported that there is 4-fold more IL-1β production in individuals who are
homozygous for IL-1β +3954 TT genotype and 2-fold increase in heterozygous CT individuals
(Pociot F, 1992). Al-Qawasmi had suggested that the IL-1β polymorphism at +3954, especially
the CC genotype, may lead to decreased production of IL-1β. A study of IL-1β knockout mice
does support the theory that a decreased level of IL-1β results in increased root resorption (R. A.
Al-Qawasmi, 2003; R. a Al-Qawasmi, 2004). Orthodontic tooth movement happens by
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resorption of bone on the pressure side and deposition of bone on tension side. IL-1β is
responsible for recruitment of osteoclasts and bone resorption. It is plausible that low levels of
IL-1β may lead to decreased remodeling of the bone, leading to prolonged stress concentration
on the roots during orthodontic treatment. This prolonged stress can lead to increased root
resorption under dynamic forces applied during orthodontic treatment (R. A. Al-Qawasmi, 2003;
R. a Al-Qawasmi, 2004).
This study suggests that SRA may have a racial predilection, with Hispanic groups more
prone to SRA. Also, it indicates that the +3954 CC IL-1β genotype may be a risk factor for root
resorption during orthodontic treatment. This allelic variation may be more prevalent in Hispanic
groups. Patients of Hispanic origin with a radiographic indication of SRA and the presence of the
IL-1β (+3954) CC genotype may be at higher risk than individuals exhibiting SRA with the TT
or CT genotype. These findings support the multifactorial nature of root resorption; a patient
may present with one of the risk factors and yet not exhibit resorption of roots during orthodontic
treatment. Long duration of treatment, extractions to close a large overjet or excessive torque of
incisors can put a predisposed patient at risk for significant root resorption. These treatment
mechanics combined with other factors like a unique genetic polymorphism or indications of
SRA will put the patient at higher risk for root resorption. Diagnosing these risk factors,
including single nucleotide polymorphisms, before the start of treatment is important when
treatment planning for these patients.
Evaluating genetic risk factors for root resorption prior to orthodontic treatment could
serve as an important diagnostic tool. Buccal swabs or even saliva samples can be taken chair
side prior to the start of the treatment. DNA can be isolated and analyzed for any genetic marker,
including the IL-1β gene polymorphism at +3954, that may lead to increase susceptibility to root
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resorption during treatment. Diagnostic aids like CBCT and genetic analysis using a simple
buccal swab and laboratory procedure may be able to help identify the patients at high risk for
root resorption and these patients could be informed about their increased risk and treatment
altered accordingly.
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Chapter 6, Conclusions:
1) All of the patients in the SRA group exhibited the CC genotype for the IL-1β gene
polymorphism at +3954. This genotype has been implicated in causing increased root
resorption by possibly decreasing IL-1β production and increasing the stress on root
apices during orthodontic tooth movement.
2) In our study, Hispanic and Female patients showed more radiographic evidence of SRA.
3) Hispanic patients showed a higher prevalence of the CC genotype at +3954. This
observation combined with the observation of a higher prevalence of Hispanic patients
presenting with SRA suggests that Hispanic patients may be at a higher risk for
orthodontically induced root resorption due to this genotype.
4) Caucasian patients did not show any significant difference between the different IL-1β
+3954 genotypes. This suggests that Caucasian patients may be less prone to root
resorption as compared to patients of Hispanic origin.
5) All of the Asian patients exhibited the CC genotype at IL-1β +3954 but the sample size
was too small to derive any statistically significant conclusion.
6) No African-American patients were identified that exhibited SRA during the period of
patient recruitment.
7) There was no correlation evident between the IL-1β gene polymorphisms at -511 or -31
with SRA or normal roots.
8) This study shows that orthodontically induced root resorption is multifactorial and the
presence of one risk factor does not mean that a patient will experience root resorption
during orthodontic treatment.
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9) Multiple diagnostic measures are needed to evaluate the risk factors prior to orthodontic
treatment.
10) CBCT can help diagnose the presence of abnormal root morphology accurately.
11) DNA analysis using cheek swabs may serve as a valuable diagnostic aid to evaluate a
patient’s genetic predisposition towards root resorption. This type of analysis should be a
part of normal orthodontic records to evaluate a patient’s risk factors and aid in
formulation of a treatment plan accordingly.
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Chapter 7, Future studies
1) A larger sample size of patients with SRA and normal roots may be helpful in providing
more conclusive data.
2) This study can be expanded to evaluate the prevalence of polymorphisms between
different ethnicities. This would require equal distribution of patients from different
ethnicities.
3) In our study, we chose to de-identify all patients after collecting their DNA. Future
studies can be designed to identify patients who exhibit the IL-1β +3954 polymorphism
at the start of treatment. These patients can then be followed with regular radiographs and
CBCT scans to evaluate root resorption during the course of orthodontic treatment. This
would be especially valuable for patients exhibiting CC genotype.
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